Deutsch English Français

Contact

EP0619814

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0619814

EP0619814 - OXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINIC AGONIST ACTIVITY [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 20.03.1998 Database last updated on 14.06.2024
Most recent event Tooltip	20.03.1998	Application deemed to be withdrawn	published on 06.05.1998 [1998/19]
Applicant(s)	For all designated states FUJISAWA PHARMACEUTICAL CO., LTD. 4-7, Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-8514 / JP
	[N/P]
Former [1994/42]	For all designated states FUJISAWA PHARMACEUTICAL CO., LTD. 4-7, Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541 / JP
Inventor(s)	01 / TAKASUGI, Hisashi 3-116-10, Mozu Umekita Sakai-shi Osaka 591 / JP
	02 / KUNO, Atsushi 24-6, Shinkofudai 5-chome Toyono-cho Toyono-gun Osaka 563-01 / JP
	03 / OHKUBO, Mitsuru 5-1-65, Fushimidai Inagawa-cho Kawabe-gun Hyogo 666-02 / JP
	[1994/42]
Representative(s)	Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte Brucknerstraße 20 40593 Düsseldorf / DE
	[N/P]
Former [1994/42]	Türk, Gille, Hrabal, Leifert Brucknerstrasse 20 D-40593 Düsseldorf / DE
Application number, filing date	93900416.4	18.12.1992
	[1994/42]
	WO1992JP01658
Priority number, date	GB19910027533	31.12.1991 Original published format: GB 9127533
	GB19920020904	05.10.1992 Original published format: GB 9220904
	[1994/42]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9313083
	Date:	08.07.1993
	Language:	EN
	[1993/16]
	Type:	A1 Application with search report
	No.:	EP0619814
	Date:	19.10.1994
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 08.07.1993 takes the place of the publication of the European patent application.
	[1994/42]
Search report(s)	International search report - published on:	EP	08.07.1993
Classification	IPC:	C07D271/06, C07D453/02, C07D413/12, C07D413/06, C07D271/00, A61K31/41, A61K31/445	[1994/42]
	CPC:	C07D271/06 (EP,US); A61P25/28 (EP); A61P27/16 (EP); A61P43/00 (EP); C07D413/10 (EP,US); C07D413/14 (EP,US); (+) C07D453/02 (EP,US); Y02P20/55 (EP,US) (-)
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1994/42]
Title	German:	OXADIAZOLDERIVATE MIT ACETYCHOLINESTERASE-HEMMENDER UND MUSCARIN-AGONISTISCHER WIRKUNG	[1994/42]
	English:	OXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINIC AGONIST ACTIVITY	[1994/42]
	French:	DERIVES D'OXADIAZOLE A EFFET INHIBITEUR DE L'ACETYLCHOLINESTERASE ET AGONISTE MUSCARINIQUE	[1994/42]
Entry into regional phase	13.07.1994	National basic fee paid
	13.07.1994	Designation fee(s) paid
	13.07.1994	Examination fee paid
Examination procedure	15.07.1993	Request for preliminary examination filed International Preliminary Examining Authority: EP
	13.07.1994	Examination requested [1994/42]
	23.10.1995	Despatch of a communication from the examining division (Time limit: M04)
	23.02.1996	Reply to a communication from the examining division
	14.10.1996	Despatch of a communication from the examining division (Time limit: M06)
	10.04.1997	Reply to a communication from the examining division
	18.06.1997	Despatch of a communication from the examining division (Time limit: M04)
	29.10.1997	Application deemed to be withdrawn, date of legal effect [1998/19]
	25.11.1997	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1998/19]
Fees paid	Renewal fee
	07.12.1994	Renewal fee patent year 03
	08.12.1995	Renewal fee patent year 04
	11.12.1996	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	31.12.1997	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]EP0459568 (MERCK SHARP & DOHME [GB]);
		[X]EP0402056 (BEECHAM GROUP PLC [GB]);
		[X]EP0363085 (BEECHAM GROUP PLC [GB]);
		[X]EP0328200 (MERCK SHARP & DOHME [GB]);
		[X]EP0323864 (MERCK SHARP & DOHME [GB]);
		[X]EP0316718 (FERROSAN AS [DK]);
		[X]EP0301729 (MERCK SHARP & DOHME [GB]);
		[X]EP0261763 (BEECHAM GROUP PLC [GB]);
		[X]EP0259621 (FERROSAN AS [DK]);
		[X]EP0239309 (MERCK SHARP & DOHME [GB]);
		[X]FR1481025 (ACRAF);
		[X]FR2247213 (DELALANDE SA [FR])
		[X] - JOURNAL OF MEDICINAL CHEMISTRY vol. 33, no. 10, October 1990, WASHINGTON US pages 2690 - 2697 L.J. STREET ET AL. 'Synthesis and Biological Activity of 1,2,4-Oxadiazole Derivatives: Highly Potent and Efficacious Agonists for Cortical Muscarinic Receptors'
		[X] - ATHEROSCLEROSIS vol. 17, 1973, AMSTERDAM, NL pages 121 - 129 Y. IMAI ET AL. 'Biological Studies of AT-308. Part 1. Hypocholesterolemic effect of 1,2,4-oxadiazole derivatives in rats.'

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p